Cardio Diagnostics Holdings Inc is trading at $2.44 (+14.55%) as momentum builds around the company's upcoming presentation schedule.

  • The primary catalyst is a May 27 announcement that the company will showcase its AI-powered cardiovascular solutions at four national benefits conferences throughout June.
  • While firm broader U.S. equity markets are providing a supportive backdrop, the specific conference schedule is the direct driver of today's price action.